FDA Approves Material Threat Medical Countermeasure Product

Summary

The FDA has approved FABHALTA (iptacopan) capsules, a material threat medical countermeasure product, following the issuance of a priority review voucher, as required by the Federal Food, Drug, and Cosmetic Act.